10 April 2019
US Justice Department indictment of Indivior Plc
RB Group Plc notes the 9 April 2019 indictment by the US Justice Department in relation to Indivior Plc and Indivior Inc, the pharmaceuticals business which was demerged from RB at the end of 2014
This indictment is not against RB Group Plc or any other group company and we currently have no additional or new information in respect of this matter, apart from what has been publicly issued by the Department of Justice and Indivior Plc.
Investors are referred to previous public statements including Note 19 in our 2018 Annual Report in which we state that at 31 December 2018 the company was recognising a provision (denominated in dollars) of $400m or £313m.
The information contained in Note 19 of our annual report remains our most up to date statement.
For further information, please contact:
RB Richard Joyce SVP, Investor Relations James Tilley Director, Investor Relations Patty O'Hayer Director, External Relations and Government Affairs |
+44 (0) 1753 217800 |
Finsbury (Financial PR) Philip Walters |
+44 (0) 20 7251 3801 |
LEI: 5493003JFSMOJG48V108
